List of Tables
    Table 1. Budesonide Inhaler CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Budesonide Inhaler Market Trends
    Table 3. Budesonide Inhaler Market Drivers
    Table 4. Budesonide Inhaler Market Challenges
    Table 5. Budesonide Inhaler Market Restraints
    Table 6. Global Budesonide Inhaler Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Budesonide Inhaler Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Budesonide Inhaler Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Budesonide Inhaler Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Budesonide Inhaler Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Budesonide Inhaler Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Budesonide Inhaler Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Budesonide Inhaler Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Budesonide Inhaler Sales Share by Manufacturer, 2017-2022
    Table 15. Global Budesonide Inhaler Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Budesonide Inhaler Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Budesonide Inhaler by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Budesonide Inhaler as of 2021)
    Table 18. Top Players of Budesonide Inhaler in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Budesonide Inhaler Product Type
    Table 20. Date of International Manufacturers Enter into Budesonide Inhaler Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Budesonide Inhaler Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Budesonide Inhaler Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Budesonide Inhaler Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Budesonide Inhaler Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Budesonide Inhaler Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Budesonide Inhaler Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Budesonide Inhaler Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Budesonide Inhaler Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Budesonide Inhaler Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Budesonide Inhaler Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Budesonide Inhaler Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Budesonide Inhaler Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Budesonide Inhaler Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Budesonide Inhaler Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Budesonide Inhaler Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Budesonide Inhaler Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Budesonide Inhaler Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Budesonide Inhaler Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Budesonide Inhaler Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Budesonide Inhaler Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. AstraZeneca Corporation Information
    Table 43. AstraZeneca Description and Business Overview
    Table 44. AstraZeneca Budesonide Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. AstraZeneca Budesonide Inhaler Product
    Table 46. AstraZeneca Recent Development
    Table 47. Cosmo Pharmaceuticals Corporation Information
    Table 48. Cosmo Pharmaceuticals Description and Business Overview
    Table 49. Cosmo Pharmaceuticals Budesonide Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Cosmo Pharmaceuticals Product
    Table 51. Cosmo Pharmaceuticals Recent Development
    Table 52. Teva Pharmaceutical Corporation Information
    Table 53. Teva Pharmaceutical Description and Business Overview
    Table 54. Teva Pharmaceutical Budesonide Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Teva Pharmaceutical Product
    Table 56. Teva Pharmaceutical Recent Development
    Table 57. Novartis Corporation Information
    Table 58. Novartis Description and Business Overview
    Table 59. Novartis Budesonide Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Novartis Product
    Table 61. Novartis Recent Development
    Table 62. Mylan Corporation Information
    Table 63. Mylan Description and Business Overview
    Table 64. Mylan Budesonide Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Mylan Product
    Table 66. Mylan Recent Development
    Table 67. Pfizer Corporation Information
    Table 68. Pfizer Description and Business Overview
    Table 69. Pfizer Budesonide Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Pfizer Product
    Table 71. Pfizer Recent Development
    Table 72. Dr. Falk Pharma Corporation Information
    Table 73. Dr. Falk Pharma Description and Business Overview
    Table 74. Dr. Falk Pharma Budesonide Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Dr. Falk Pharma Product
    Table 76. Dr. Falk Pharma Recent Development
    Table 77. Chiesi Farmaceutici Corporation Information
    Table 78. Chiesi Farmaceutici Description and Business Overview
    Table 79. Chiesi Farmaceutici Budesonide Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Chiesi Farmaceutici Product
    Table 81. Chiesi Farmaceutici Recent Development
    Table 82. Orion Corporation Corporation Information
    Table 83. Orion Corporation Description and Business Overview
    Table 84. Orion Corporation Budesonide Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Orion Corporation Product
    Table 86. Orion Corporation Recent Development
    Table 87. Cipla Limited Corporation Information
    Table 88. Cipla Limited Description and Business Overview
    Table 89. Cipla Limited Budesonide Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Cipla Limited Product
    Table 91. Cipla Limited Recent Development
    Table 92. Bausch Health Companies Corporation Information
    Table 93. Bausch Health Companies Description and Business Overview
    Table 94. Bausch Health Companies Budesonide Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. Bausch Health Companies Product
    Table 96. Bausch Health Companies Recent Development
    Table 97. Takeda Pharmaceutical Corporation Information
    Table 98. Takeda Pharmaceutical Description and Business Overview
    Table 99. Takeda Pharmaceutical Budesonide Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 100. Takeda Pharmaceutical Product
    Table 101. Takeda Pharmaceutical Recent Development
    Table 102. Lupin Limited Corporation Information
    Table 103. Lupin Limited Description and Business Overview
    Table 104. Lupin Limited Budesonide Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 105. Lupin Limited Product
    Table 106. Lupin Limited Recent Development
    Table 107. Synmosa Biopharma Corporation Corporation Information
    Table 108. Synmosa Biopharma Corporation Description and Business Overview
    Table 109. Synmosa Biopharma Corporation Budesonide Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. Synmosa Biopharma Corporation Product
    Table 111. Synmosa Biopharma Corporation Recent Development
    Table 112. Lunan Better Pharmaceutical Corporation Information
    Table 113. Lunan Better Pharmaceutical Description and Business Overview
    Table 114. Lunan Better Pharmaceutical Budesonide Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. Lunan Better Pharmaceutical Product
    Table 116. Lunan Better Pharmaceutical Recent Development
    Table 117. Shanghai Sine Pharmaceutical Laboratories Corporation Information
    Table 118. Shanghai Sine Pharmaceutical Laboratories Description and Business Overview
    Table 119. Shanghai Sine Pharmaceutical Laboratories Budesonide Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. Shanghai Sine Pharmaceutical Laboratories Product
    Table 121. Shanghai Sine Pharmaceutical Laboratories Recent Development
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Budesonide Inhaler Customers List
    Table 125. Budesonide Inhaler Distributors List
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Budesonide Inhaler Product Picture
    Figure 2. Global Budesonide Inhaler Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Budesonide Inhaler Market Size 2017-2028 (US$ Million)
    Figure 4. Global Budesonide Inhaler Sales 2017-2028 (K Units)
    Figure 5. United States Budesonide Inhaler Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Budesonide Inhaler Market Size 2017-2028 (US$ Million)
    Figure 7. United States Budesonide Inhaler Sales 2017-2028 (K Units)
    Figure 8. United States Budesonide Inhaler Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Budesonide Inhaler Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Budesonide Inhaler Report Years Considered
    Figure 11. Product Picture of Dry Powder
    Figure 12. Product Picture of Suspension
    Figure 13. Product Picture of Sprays
    Figure 14. Global Budesonide Inhaler Market Share by Type in 2022 & 2028
    Figure 15. Global Budesonide Inhaler Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Budesonide Inhaler Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Budesonide Inhaler Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Budesonide Inhaler Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Budesonide Inhaler Price by Type (2017-2028) & (USD/Unit)
    Figure 20. United States Budesonide Inhaler Market Share by Type in 2022 & 2028
    Figure 21. United States Budesonide Inhaler Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Budesonide Inhaler Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Budesonide Inhaler Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Budesonide Inhaler Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Budesonide Inhaler Price by Type (2017-2028) & (USD/Unit)
    Figure 26. Product Picture of Hospital Pharmacies
    Figure 27. Product Picture of Retail Pharmacies
    Figure 28. Product Picture of Online Pharmacies
    Figure 29. Global Budesonide Inhaler Market Share by Application in 2022 & 2028
    Figure 30. Global Budesonide Inhaler Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Budesonide Inhaler Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Budesonide Inhaler Sales by Application (2017-2028) & (K Units)
    Figure 33. Global Budesonide Inhaler Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Budesonide Inhaler Price by Application (2017-2028) & (USD/Unit)
    Figure 35. United States Budesonide Inhaler Market Share by Application in 2022 & 2028
    Figure 36. United States Budesonide Inhaler Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Budesonide Inhaler Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Budesonide Inhaler Sales by Application (2017-2028) & (K Units)
    Figure 39. United States Budesonide Inhaler Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Budesonide Inhaler Price by Application (2017-2028) & (USD/Unit)
    Figure 41. North America Budesonide Inhaler Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 42. North America Budesonide Inhaler Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Budesonide Inhaler Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Budesonide Inhaler Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Budesonide Inhaler Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 46. Europe Budesonide Inhaler Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Budesonide Inhaler Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Budesonide Inhaler Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Budesonide Inhaler Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Budesonide Inhaler Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Budesonide Inhaler Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Budesonide Inhaler Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 53. Asia-Pacific Budesonide Inhaler Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Budesonide Inhaler Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Budesonide Inhaler Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Budesonide Inhaler Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Budesonide Inhaler Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Budesonide Inhaler Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Budesonide Inhaler Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Budesonide Inhaler Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Budesonide Inhaler Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Budesonide Inhaler Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Budesonide Inhaler Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Budesonide Inhaler Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 65. Latin America Budesonide Inhaler Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Budesonide Inhaler Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Budesonide Inhaler Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Budesonide Inhaler Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Budesonide Inhaler Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 70. Middle East & Africa Budesonide Inhaler Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Budesonide Inhaler Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Budesonide Inhaler Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. U.A.E Budesonide Inhaler Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Budesonide Inhaler Value Chain
    Figure 75. Budesonide Inhaler Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed